Pages that link to "Q47217213"
Jump to navigation
Jump to search
The following pages link to Perioperative events influence cancer recurrence risk after surgery. (Q47217213):
Displaying 28 items.
- Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer (Q56795836) (← links)
- Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling (Q57020351) (← links)
- High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer (Q89630253) (← links)
- Harnessing cancer immunotherapy during the unexploited immediate perioperative period (Q89748459) (← links)
- The immunosuppressive effects of volatile versus intravenous anesthesia combined with epidural analgesia on kidney cancer: a pilot randomized controlled trial (Q89878260) (← links)
- The volatile anesthetic sevoflurane reduces neutrophil apoptosis via Fas death domain-Fas-associated death domain interaction (Q90075989) (← links)
- Effects of Lidocaine and Src Inhibition on Metastasis in a Murine Model of Breast Cancer Surgery (Q90225077) (← links)
- The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study (Q90364854) (← links)
- MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription (Q90632365) (← links)
- Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial (Q90909722) (← links)
- Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial (Q91686245) (← links)
- Impact of perioperative red blood cell transfusion on postoperative recovery and long-term outcome in patients undergoing surgery for ovarian cancer: A propensity score-matched analysis (Q91990317) (← links)
- Dual Actions of Ketorolac in Metastatic Ovarian Cancer (Q92178752) (← links)
- Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study (Q92705573) (← links)
- Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases (Q92789482) (← links)
- Surgical stress and cancer progression: the twisted tango (Q93060376) (← links)
- Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review (Q93126609) (← links)
- Improving cancer immunotherapy through nanotechnology (Q93162619) (← links)
- A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy (Q93216487) (← links)
- Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies (Q96167094) (← links)
- Reducing injury response to surgery with repurposed drugs: An evolving approach to prevention of cancer metastases (Q96350552) (← links)
- Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial (Q96350609) (← links)
- Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study (Q97529789) (← links)
- Tumor Excision as a Metastatic Russian Roulette: Perioperative Interventions to Improve Long-Term Survival of Cancer Patients (Q97566222) (← links)
- Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study (Q97678288) (← links)
- Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population (Q97874907) (← links)
- The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer? (Q99605680) (← links)
- Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma (Q123350948) (← links)